Oruka Therapeutics, Inc. · NASDAQ:ORKA

Quinlan Paul T sold 10,000 Oruka Therapeutics, Inc. shares (Form 4)

Traded Sep 21, 2026 · Filed Sep 21, 2026

On Sep 21, 2026, Quinlan Paul T (General Counsel) sold 10,000 Oruka Therapeutics, Inc. shares at an average US$93.64 for US$936K under a trading plan, leaving 29,995 shares. Filed Sep 21, 2026 (Form 4).

Sold: 10,000 shares
Price: US$93.64 average (US$92.37 to US$95.31)
Value: US$936K
Holding after: 29,995 shares
Trading plan: Yes (Made under a plan set in advance)
Role: General Counsel

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 21, 2026	Common Stock	Option exercise	10,000	US$7.80	39,995	Direct
Sep 21, 2026	Common Stock	Sale	2,900	US$92.37	37,095	Direct
Sep 21, 2026	Common Stock	Sale	3,832	US$93.32	33,263	Direct
Sep 21, 2026	Common Stock	Sale	601	US$94.44	32,662	Direct
Sep 21, 2026	Common Stock	Sale	2,667	US$95.31	29,995	Direct

Source

View original at SEC

Related